BRKR

Over the past six months, Bruker's stock price has been impacted by its earnings reports and strategic announcements. In Q2 2026, Bruker reported EPS of $0.49, beating estimates, but revenue of $838.5 million missed forecasts, leading to a 16.82% plunge in shares due to a soft growth outlook. Despite this, non-GAAP operating margin expanded to 14.1% due to cost cuts and tariff benefits, and organic revenue growth returned at 2.8%. The company maintained its full-year EPS guidance but cut its FX tailwind assumption, while the organic revenue growth outlook remained unchanged at 1%-2% for 2026. On August 14, 2026, Bruker Corporation declared a quarterly cash dividend of $0.05 per share, payable on October 7, 2026. In September 2026, Bruker announced a multi-system high-field NMR order exceeding $6 million from UC Berkeley and Bruker Energy & Supercon Technologies partnered with Luvata Materials & Solutions to expand the industrial readiness of high-performance RRP superconductors. In August 2026, the company acquired a minority stake in Atinary Technologies and launched new products like the eWARP TKD detector and the XFlash FlatQUAD 2L.